A Unified OS for Drug Development: Our Investment in Cheiron
Menlo Ventures Menlo Ventures
Cheiron, a startup building a software platform for drug development, raised $8 million in seed funding led by Menlo Ventures with backing from industry figures including Moderna co-founder Robert Langer and former Pfizer CMO Freda Lewis-Hall. The platform uses a Lifesciences Knowledge Graph to integrate biomedical, clinical, regulatory, and commercial data into a queryable system that helps drug teams track program state across multiple functions simultaneously. Cheiron has already secured seven of Korea's top 10 biopharma companies as customers in less than six months and is now expanding into the U.S. market.
Why it matters
Drug development is one of the hardest problems in the world. It takes a decade, costs billions, and fails 90% of the time. Much of this is a natural consequence of how complex these programs are. A drug in development touches clinical, regulatory, manufacturing, and commercial functions all at once, generating knowledge across each that […] The post A Unified OS for Drug Development: Our Investment in Cheiron appeared first on Menlo Ventures.
